Epithalon // Telomerase Activator
A synthetic tetrapeptide that activates telomerase — the enzyme responsible for maintaining and lengthening telomeres, the protective caps on your chromosomes that shorten with every cell division. Developed by Vladimir Khavinson over 35 years of research. The most direct telomere-targeting compound available.
Turning back the cellular clock.
Every time a cell divides, telomeres shorten. When they reach a critical length, the cell enters senescence or dies. Epithalon activates telomerase to maintain and restore telomere length — addressing aging at the most fundamental level.
Short bursts, quarterly repeats.
Epithalon follows the Khavinson burst protocol — intensive short courses that trigger lasting cellular changes. 10–20 day bursts repeated 2–4 times per year. No continuous dosing required.
Khavinson's telomere research legacy.
Vladimir Khavinson's work on Epithalon spans over 35 years at the Saint Petersburg Institute of Bioregulation and Gerontology. His research established that short peptides can directly interact with DNA to modulate gene expression — a concept he calls 'peptide bioregulation.'
Key studies demonstrated that Epithalon activates telomerase in human somatic cells, extending the Hayflick limit — the maximum number of divisions a cell can undergo. In cell culture studies, Epithalon-treated fibroblasts showed 44% telomere elongation and overcame the normal replicative senescence limit.
Animal studies showed lifespan extension in mice and rats receiving Epithalon courses, with improved biomarkers of aging including antioxidant enzyme activity, immune function, and melatonin production. Human studies in elderly populations showed improved melatonin rhythms and general health markers.
Longevity peptide landscape.
| Compound | Target | Protocol | Mechanism | Data Level |
|---|---|---|---|---|
| Epithalon | Telomeres | 10–20 day bursts | Telomerase Activation | 35yr research |
| FOXO4-DRI | Senescent Cells | 3–5 day bursts | Senolytic (p53) | Preclinical |
| MOTS-C | Mitochondria | 3x/week continuous | AMPK Activation | Emerging |
| SS-31 | Mito Membrane | Daily | Cardiolipin Binding | Phase 3 |
| NAD+/NMN | Cellular Energy | Daily oral | Sirtuin Activation | Extensive |
What to watch for.
Epithalon's side effect profile is manageable with proper protocol adherence. Baseline blood work before starting and periodic monitoring during use is essential.
- Extremely well tolerated across all published data
- Injection site reactions (very mild, transient)
- No significant adverse events reported
- Khavinson bioregulators have excellent safety profiles
- Theoretical cancer concern (telomerase in tumor cells) — unconfirmed
- Sleep pattern changes (melatonin modulation — usually positive)
- Telomere length testing (baseline and post-cycle)
- Melatonin levels (AM cortisol/PM melatonin rhythm)
- Complete blood count with differential
- Comprehensive metabolic panel
- IGF-1 (general aging marker)
- hsCRP (inflammation baseline)
- Antioxidant capacity (if available)
- MOTS-C for mitochondrial + telomere longevity coverage
- SS-31 for mitochondrial membrane protection
- Thymalin for combined Khavinson bioregulator protocol
- Pinealon for pineal gland restoration synergy
- FOXO4-DRI for senolytic clearance (separate burst cycles)
- Space different bioregulator bursts — don't overlap
- Lyophilized: refrigerate at 2–8°C (36–46°F)
- Reconstituted: refrigerate, use within 14–21 days
- Protect from light
- Do not freeze reconstituted solution
- Tetrapeptide — relatively stable molecule
Compounds that complement Epithalon.
The most direct intervention for biological aging — period.
Epithalon is the only compound that directly activates telomerase in human somatic cells. Khavinson's 35 years of research represents the most sustained investigation into peptide-mediated longevity ever conducted. The burst protocol is simple: 10–20 days on, months off, repeat quarterly. Stack with MOTS-C for mitochondrial coverage, Thymalin for immune restoration, and Pinealon for circadian repair — the complete Khavinson bioregulator longevity protocol. Get telomere length testing before your first cycle and annually thereafter. The theoretical cancer concern (telomerase in existing tumors) remains unconfirmed but warrants baseline screening.
Our free Protocol Guide includes the complete Anti-Aging Stack with Epithalon — burst timing, telomere tracking, bioregulator stacking, and monitoring templates.